Novavax, Inc.
NVAX
$9.03
$0.5456.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 106.51M | 518.65M | -81.03M | -121.30M | 162.38M |
| Total Depreciation and Amortization | 7.56M | 8.34M | 12.52M | 12.70M | 11.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.20M | 27.11M | -56.00M | 16.15M | 25.53M |
| Change in Net Operating Assets | -240.33M | -739.60M | -48.65M | -52.37M | 115.23M |
| Cash from Operations | -127.46M | -185.50M | -173.16M | -144.81M | 314.27M |
| Capital Expenditure | -247.00K | -1.22M | -1.93M | -1.37M | -2.88M |
| Sale of Property, Plant, and Equipment | -- | -- | 192.64M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 111.35M | -72.10M | -46.70M | 33.28M | -369.83M |
| Cash from Investing | 111.10M | -73.32M | 144.01M | 31.91M | -372.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -612.00K | -2.20M | -2.76M | -512.00K | -366.00K |
| Issuance of Common Stock | -- | -- | -- | 415.00K | 257.97M |
| Repurchase of Common Stock | -5.29M | -- | -666.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.86M | -4.86M | -- | -- | 616.00K |
| Cash from Financing | -1.04M | -7.06M | -3.42M | -97.00K | 258.22M |
| Foreign Exchange rate Adjustments | 7.91M | -930.00K | -10.72M | 6.03M | -156.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.50M | -266.81M | -43.30M | -106.97M | 199.62M |